Gainers
- Lucy Scientific Discovery LSDI shares moved upwards by 205.8% to $1.56 during Thursday's regular session. The company's market cap stands at $2.7 million.
- SINTX Techs SINT shares moved upwards by 31.66% to $0.17. The company's market cap stands at $20.6 million. As per the news, the Q1 earnings report came out 3 days ago.
- Nanoviricides NNVC stock increased by 23.56% to $2.22. The market value of their outstanding shares is at $26.1 million. The company's, Q3 earnings came out yesterday.
- Scorpius Holdings SCPX shares moved upwards by 23.35% to $0.1. The company's market cap stands at $3.4 million.
- Onconetix ONCO stock moved upwards by 23.29% to $0.14. The market value of their outstanding shares is at $3.0 million.
- NRX Pharmaceuticals NRXP stock increased by 19.98% to $3.88. The market value of their outstanding shares is at $40.9 million. As per the news, the Q1 earnings report came out 2 days ago.
Losers
- Eyenovia EYEN stock decreased by 24.1% to $0.81 during Thursday's regular session. The market value of their outstanding shares is at $41.0 million. The company's, Q1 earnings came out yesterday.
- 180 Life Sciences ATNF stock decreased by 22.17% to $1.51. The company's market cap stands at $1.3 million. As per the news, the Q1 earnings report came out yesterday.
- Omeros OMER stock decreased by 20.99% to $3.29. The market value of their outstanding shares is at $190.9 million. The company's, Q1 earnings came out yesterday.
- Elicio Therapeutics ELTX shares fell 17.31% to $8.6. The market value of their outstanding shares is at $87.9 million. As per the press release, Q1 earnings came out yesterday.
- Biotricity BTCY stock decreased by 11.41% to $1.01. The company's market cap stands at $9.5 million.
- T2 Biosystems TTOO stock decreased by 10.22% to $5.36. The market value of their outstanding shares is at $72.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in